Have Insiders Sold Edwards Lifesciences Shares Recently?

Anyone interested in Edwards Lifesciences Corporation (NYSE:EW) should probably be aware that a company insider, Daniel Lippis, recently divested US$327k worth of shares in the company, at an average price of US$79.46 each. The eyebrow raising move amounted to a reduction of 25% in their holding.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Edwards Lifesciences Insider Transactions Over The Last Year

In fact, the recent sale by Daniel Lippis was the biggest sale of Edwards Lifesciences shares made by an insider individual in the last twelve months, according to our records. So we know that an insider sold shares at around the present share price of US$78.49. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

Edwards Lifesciences insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Edwards Lifesciences

If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.

Insider Ownership Of Edwards Lifesciences

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Edwards Lifesciences insiders own 0.9% of the company, currently worth about US$431m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

What Might The Insider Transactions At Edwards Lifesciences Tell Us?

Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. On the plus side, Edwards Lifesciences makes money, and is growing profits. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Edwards Lifesciences.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.